Multan and several parts of South Punjab are facing a severe smog crisis, causing a critical shortage of inhalers and a sharp rise in their prices. The ...
Teva Pharmaceuticals has agreed to pay $35 million and withdraw six patents from a U.S. regulatory list to settle claims that the drugmaker delayed generic competition for its QVAR asthma inhalers, ...
According to details surfaced on Wednesday, the Air Quality Index (AQI) in the region has exceeded 500, creating serious ...
StockStory.org on MSN
3 Volatile Stocks We Approach with Caution
Detailed price information for Newmark Group Inc Cl A (NMRK-Q) from The Globe and Mail including charting and trades.
StockStory.org on MSN
3 Unpopular Stocks We Keep Off Our Radar
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue ...
Teva Pharmaceuticals has agreed to pay $35 million to resolve a major antitrust lawsuit alleging that the company ...
Findings showed BDP/FF/G improved predose FEV1 and reduced the rate of moderate to severe exacerbations compared with BDP/FF. The Food and Drug Administration (FDA) has accepted for review the New ...
Real-world asthma medication adherence averages around 50% for children, with even lower rates in non-Hispanic Black children. A multifaceted intervention with financial incentives increased asthma ...
CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta agonist (ICS/LAMA/LABA) improved lung function and reduced exacerbations in ...
Hosted on MSN
Afternoon could be best time for asthma inhaler
Scientists have found the optimal time asthma patients should use inhalers to slash the risk of a potentially deadly attack. For asthma sufferers using a brown inhaler the best time of day is in the ...
President Donald Trump announced on Friday a deal with drugmaker AstraZeneca in his latest effort to lower drug costs through so-called “Most Favored Nation” pricing. The move comes after the ...
Teva reports revenues of $4.5 billion in the third quarter of 2025, an increase of 3% year-over-year (YoY) in U.S. dollars or 1% in local currency (LC). Excluding Japan BV in Q3 2024, revenues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results